Pulmonology

Your Article Summary

See Latest Articles

Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09

Novartis announced that the company has completed its entire shipment of seasonal influenza vaccine to the United States for the 2009/2010 season. As previously anticipated, the company delivered 27 million doses of Fluvirin influenza virus vaccine, which has been approved by the U.S. Food and Drug Administration. Novartis completed this season's shipment earlier than in previous years, in anticipation of demand for earlier vaccination with seasonal influenza vaccine created by the current global A(H1N1) influenza pandemic.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Medtronic Receives FDA Approval for Industry’s Most Advanced Integrated System for Diabetes Management
Medtronic, 03/22/10

Medtronic Receives FDA Panels Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System
Medtronic, 03/22/10

Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
Novartis, 03/19/10

 See all of Drug/Product Approvals

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Commercialization in close cooperation with RIEMSER Arzneimittel AG
b3c newswire, 03/22/10

Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market
BMC Clinical Pharmacology, 03/19/10

Maximus acquires Canadian-based Deltaware
Canadian Healthcare Technology, 03/19/10

 See all of Marketing/Media/ROI